Trial NCT01436305

View at ClinicalTrials.gov 
Org. Study IDs: DAIT CTOT-10

Last trial update was posted on 2017-09-27

MeSH Interventions

Abatacept Alemtuzumab Basiliximab Methylprednisolone Mycophenolic Acid Tacrolimus

MeSH Conditions


Other Conditions

Kidney Transplantation Renal Transplantation

Stopping Reasons

Secondary to safety concerns plus change in Campath® (alemtuzumab) availability.

Limitations And Caveats

Enrollment of 210 participants was planned, but study was stopped after 19 participants enrolled due to safety concerns and change in alemtuzumab availability. Enrolled participants continued follow-up after enrollment ended.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID